Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Prominent bronchial vasculature, hemoptysis, and bilateral ground-glass opacities in a young woman with mitral stenosis.

Aigner F, Speich R, Schuurmans MM.

J Bras Pneumol. 2016 Sep-Oct;42(5):386. doi: 10.1590/S1806-37562016000000151. English, Portuguese. No abstract available.

2.

Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy.

Somaini G, Hasler ED, Saxer S, Huber LC, Lichtblau M, Speich R, Bloch KE, Ulrich S.

Respiration. 2016;91(5):359-66. doi: 10.1159/000445805. Epub 2016 May 18.

3.

Reactive Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-Occlusive Disease in a Patient with Repaired Scimitar Syndrome.

Güttinger E, Vrugt B, Speich R, Ulrich S, Schwitz F, Arrigo M, Huber LC.

Case Rep Cardiol. 2016;2016:9384126. doi: 10.1155/2016/9384126. Epub 2016 Mar 16.

4.

Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.

Hasler ED, Müller-Mottet S, Furian M, Saxer S, Huber LC, Maggiorini M, Speich R, Bloch KE, Ulrich S.

Chest. 2016 Jul;150(1):57-67. doi: 10.1016/j.chest.2016.02.634. Epub 2016 Feb 15.

PMID:
26892603
5.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

PMID:
26826181
6.

Disease-Targeted Treatment Improves Cognitive Function in Patients with Precapillary Pulmonary Hypertension.

Somaini G, Stamm A, Müller-Mottet S, Hasler E, Keusch S, Hildenbrand FF, Furian M, Speich R, Bloch KE, Ulrich S.

Respiration. 2015;90(5):376-83. doi: 10.1159/000439227. Epub 2015 Oct 9.

7.

Reliability of parameters during stair ascent measured with Leonardo Mechanograph(®) Stair A in healthy subjects.

Saxer S, Speich R, Toigo M, Mueller SM, Ulrich Somaini S.

J Musculoskelet Neuronal Interact. 2015 Sep;15(3):257-63.

8.

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.

Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O.

Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.

9.

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension.

Speich R, Ulrich S, Domenighetti G, Huber LC, Fischler M, Treder U, Breitenstein A.

Respiration. 2015;89(6):515-24. doi: 10.1159/000381923. Epub 2015 Jun 3.

10.

Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells.

Huber LC, Ulrich S, Leuenberger C, Gassmann M, Vogel J, von Blotzheim LG, Speich R, Kohler M, Brock M.

Exp Biol Med (Maywood). 2015 Dec;240(12):1580-9. doi: 10.1177/1535370215579018. Epub 2015 Apr 7.

11.

The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.

Brock M, Haider TJ, Vogel J, Gassmann M, Speich R, Trenkmann M, Ulrich S, Kohler M, Huber LC.

Int J Biochem Cell Biol. 2015 Apr;61:129-37. doi: 10.1016/j.biocel.2015.02.002. Epub 2015 Feb 11.

PMID:
25681685
12.

Long-term data from the Swiss pulmonary hypertension registry.

Mueller-Mottet S, Stricker H, Domenighetti G, Azzola A, Geiser T, Schwerzmann M, Weilenmann D, Schoch O, Fellrath JM, Rochat T, Lador F, Beghetti M, Nicod L, Aubert JD, Popov V, Speich R, Keusch S, Hasler E, Huber LC, Grendelmeier P, Tamm M, Ulrich S.

Respiration. 2015;89(2):127-40. doi: 10.1159/000370125. Epub 2015 Jan 31. Erratum in: Respiration. 2015;89(5)373. Domeninghetti, Guido [corrected to Domenighetti, Guido.

13.

Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease.

Lederer H, Muggli B, Speich R, Treder U, Stricker H, Goede J, Ulrich S, Stämpfli SF, Breitenstein A.

PLoS One. 2014 Dec 12;9(12):e115219. doi: 10.1371/journal.pone.0115219. eCollection 2014.

14.

[Imatinib for pulmonary arterial hypertension].

Hoeper MM, Opitz C, Olschewski H, Ulrich S, Speich R, Behr J, Halank M, Wilkens H, Klose H, Lange TJ, Grünig E, Seeger W, Ewert R, Borst MM, Welte T, Rosenkranz S, Ghofrani HA.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S151-4. doi: 10.1055/s-0034-1387457. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489685
15.

[Supportive therapy in pulmonary arterial hypertension].

Grünig E, Ehlken N, Hohenforst-Schmidt W, Krüger U, Krüger S, Lichtblau M, Marra AM, Meyer A, Olschewski H, Olsson KM, Stähler G, Sablotzki A, Skowasch D, Wenter C, Kähler C, Ulrich S, Speich R, Lang I, Hoenen S, Meyer FJ, Bonderman D, Stark W, Hoeper MM.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S136-41. doi: 10.1055/s-0034-1387453. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489683
16.

[Quality of life in pulmonal arterial hypertension and in chronic thromboembolic pulmonary hypertension].

Halank M, Speich R, Petkova D, Saxer S, Müller-Mottet S, Hasler E, Kolditz M, Wilkens H, Ehlken N, Lichtblau M, Egenlauf B, Kähler C, Lüneburg N, Mertens D, Schulz U, Barner A, Grünig E, Puhan M, Ulrich S.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S126-35. doi: 10.1055/s-0034-1387482. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489682
17.

Effects of exercise and vasodilators on cerebral tissue oxygenation in pulmonary hypertension.

Müller-Mottet S, Hildenbrand FF, Keusch S, Hasler E, Maggiorini M, Speich R, Bloch KE, Ulrich S.

Lung. 2015 Feb;193(1):113-20. doi: 10.1007/s00408-014-9667-5. Epub 2014 Nov 21.

PMID:
25413133
18.

Experience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study.

Keusch S, Bucher A, Müller-Mottet S, Hasler E, Maggiorini M, Speich R, Ulrich S.

Multidiscip Respir Med. 2014 Oct 15;9(1):51. doi: 10.1186/2049-6958-9-51. eCollection 2014.

19.

Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.

Fossati L, Müller-Mottet S, Hasler E, Speich R, Bloch KE, Huber LC, Ulrich Somaini S.

Lung. 2014 Dec;192(6):987-95. doi: 10.1007/s00408-014-9650-1. Epub 2014 Oct 28.

PMID:
25348430
20.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
21.

Effect of oxygen and acetazolamide on nocturnal cardiac conduction, repolarization, and arrhythmias in precapillary pulmonary hypertension and sleep-disturbed breathing.

Schumacher DS, Müller-Mottet S, Hasler ED, Hildenbrand FF, Keusch S, Speich R, Bloch KE, Ulrich S.

Chest. 2014 Nov;146(5):1226-1236. doi: 10.1378/chest.14-0495.

PMID:
24991933
22.

Tobacco smoke exposure in pulmonary arterial and thromboembolic pulmonary hypertension.

Keusch S, Hildenbrand FF, Bollmann T, Halank M, Held M, Kaiser R, Kovacs G, Lange TJ, Seyfarth HJ, Speich R, Ulrich S.

Respiration. 2014;88(1):38-45. doi: 10.1159/000359972. Epub 2014 May 15.

23.

Inflammatory cytokines in pulmonary hypertension.

Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC.

Respir Res. 2014 Apr 16;15:47. doi: 10.1186/1465-9921-15-47. Review.

24.

Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial.

Ulrich S, Keusch S, Hildenbrand FF, Lo Cascio C, Huber LC, Tanner FC, Speich R, Bloch KE.

Eur Heart J. 2015 Mar 7;36(10):615-23. doi: 10.1093/eurheartj/eht540. Epub 2013 Dec 23.

25.

Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension.

Speich R, Treder U, Domenighetti G, Huber LC, Ulrich S.

Int J Clin Pharm. 2014 Apr;36(2):256-60. doi: 10.1007/s11096-013-9881-x. Epub 2013 Nov 28.

26.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

PMID:
24081973
27.

Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland.

Ulrich S, Hildenbrand FF, Treder U, Fischler M, Keusch S, Speich R, Fasnacht M.

BMC Pulm Med. 2013 Aug 5;13:49. doi: 10.1186/1471-2466-13-49.

28.

Central venous catheter infections in outpatients with pulmonary hypertension treated with continuous iloprost.

Keusch S, Speich R, Treder U, Ulrich Somaini S.

Respiration. 2013;86(5):402-6. doi: 10.1159/000350441. Epub 2013 Jun 27.

29.

Wrist actigraphy predicts outcome in patients with pulmonary hypertension.

Ulrich S, Fischler M, Speich R, Bloch KE.

Respiration. 2013;86(1):45-51. doi: 10.1159/000342351. Epub 2012 Dec 11.

30.

Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease.

Becker-Grünig T, Klose H, Ehlken N, Lichtblau M, Nagel C, Fischer C, Gorenflo M, Tiede H, Schranz D, Hager A, Kaemmerer H, Miera O, Ulrich S, Speich R, Uiker S, Grünig E.

Int J Cardiol. 2013 Sep 20;168(1):375-81. doi: 10.1016/j.ijcard.2012.09.036. Epub 2012 Oct 5.

31.

Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension.

Hildenbrand FF, Bloch KE, Speich R, Ulrich S.

Respiration. 2012;84(6):477-84. doi: 10.1159/000341182. Epub 2012 Sep 20.

32.

The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Cima K, Twiss J, Speich R, McKenna SP, Grünig E, Kähler CM, Ehlken N, Treder U, Crawford SR, Huber LC, Ulrich S.

Health Qual Life Outcomes. 2012 Sep 13;10:110. doi: 10.1186/1477-7525-10-110.

33.
34.

Pulmonary hypertension in patients with Martorell hypertensive leg ulcer: a case control study.

Glutz von Blotzheim L, Tanner FC, Noll G, Brock M, Fischler M, Hafner J, Speich R, Ulrich S, Huber LC.

Respir Res. 2012 Jun 11;13:45. doi: 10.1186/1465-9921-13-45.

35.

AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.

Brock M, Samillan VJ, Trenkmann M, Schwarzwald C, Ulrich S, Gay RE, Gassmann M, Ostergaard L, Gay S, Speich R, Huber LC.

Eur Heart J. 2014 Dec 1;35(45):3203-11. doi: 10.1093/eurheartj/ehs060. Epub 2012 Mar 26.

36.

Safety and efficacy of exercise training in various forms of pulmonary hypertension.

Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C.

Eur Respir J. 2012 Jul;40(1):84-92. doi: 10.1183/09031936.00123711. Epub 2012 Feb 9.

37.

[Supervised exercise training in patients with pulmonary arterial hypertension - analyses of the effectiveness and safety].

Saxer S, Rhyner M, Treder U, Speich R, van Gestel AJ.

Praxis (Bern 1994). 2012 Feb 1;101(3):163-8. doi: 10.1024/1661-8157/a000825. German.

PMID:
22294301
38.

Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011.

Rosenkranz S, Bonderman D, Buerke M, Felgendreher R, ten Freyhaus H, Grünig E, de Haan F, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kuebler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J.

Int J Cardiol. 2011 Dec;154 Suppl 1:S34-44. doi: 10.1016/S0167-5273(11)70491-0.

PMID:
22221972
39.

Evidence for graft colonization with periodontal pathogens in lung transplant recipients. A pilot study.

Irani S, Schmidlin PR, Bolivar I, Speich R, Boehler A.

Schweiz Monatsschr Zahnmed. 2011;121(12):1144-9.

40.

[Right heart catheterization in pulmonary hypertension].

Rosenkranz S, Behr J, Ewert R, Ghofrani HA, Grünig E, Halank M, Hoeper MM, Leuchte HH, Olschewski H, Schmeisser A, Speich R, Wilkens H, Opitz CF.

Dtsch Med Wochenschr. 2011 Dec;136(50):2601-16; quiz 2617-20. doi: 10.1055/s-0031-1292858. Epub 2011 Dec 7. Review. German. No abstract available.

PMID:
22160954
41.

Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation.

Hofer M, Schmid C, Benden C, Speich R, Inci I, Weder W, Boehler A.

J Cyst Fibros. 2012 Mar;11(2):131-6. doi: 10.1016/j.jcf.2011.10.005. Epub 2011 Nov 22.

42.

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.

Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G.

Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.

43.

MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes.

Brock M, Trenkmann M, Gay RE, Gay S, Speich R, Huber LC.

J Biol Chem. 2011 Nov 18;286(46):40142-50. doi: 10.1074/jbc.M111.251793. Epub 2011 Sep 27.

44.

Persistent photodamage following drug photosensitization in a lung-transplant recipient.

Sailer E, Kamarachev J, Boehler A, Speich R, Hofer M, Benden C, French LE, Hofbauer GF.

Photodermatol Photoimmunol Photomed. 2011 Aug;27(4):213-5. doi: 10.1111/j.1600-0781.2011.00591.x.

PMID:
21729170
45.

Diagnosing pulmonary hypertension: is there a revival of the electrocardiogram?

Speich R.

Eur Respir J. 2011 May;37(5):994-6. doi: 10.1183/09031936.00189810. No abstract available.

46.

Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis.

Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC.

Ann Rheum Dis. 2011 Aug;70(8):1482-8. doi: 10.1136/ard.2010.143040. Epub 2011 Apr 22.

47.

Human infection with Delftia tsuruhatensis isolated from a central venous catheter.

Preiswerk B, Ullrich S, Speich R, Bloemberg GV, Hombach M.

J Med Microbiol. 2011 Feb;60(Pt 2):246-8. doi: 10.1099/jmm.0.021238-0. Epub 2010 Oct 21.

PMID:
20965913
48.

[Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010].

Rosenkranz S, Bonderman D, Buerke M, Felgendreher R, ten Freyhaus H, Grünig E, de Haan F, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kübler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J; German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK).

Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S102-14. doi: 10.1055/s-0030-1263317. Epub 2010 Sep 22. German.

PMID:
20862619
49.

Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis.

Hafner J, Nobbe S, Partsch H, Läuchli S, Mayer D, Amann-Vesti B, Speich R, Schmid C, Burg G, French LE.

Arch Dermatol. 2010 Sep;146(9):961-8. doi: 10.1001/archdermatol.2010.224.

PMID:
20855694
50.

Not all intravenous immunoglobulin preparations are equally well tolerated.

Feldmeyer L, Benden C, Haile SR, Boehler A, Speich R, French LE, Hofbauer GF.

Acta Derm Venereol. 2010 Sep;90(5):494-7. doi: 10.2340/00015555-0900.

Supplemental Content

Loading ...
Support Center